{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:30:29Z","timestamp":1793817029067,"version":"4.6.1"},"reference-count":351,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.neuroscience.2011.10.057","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T05:11:02Z","timestamp":1320988262000},"page":"51-76","source":"Crossref","is-referenced-by-count":466,"special_numbering":"C","title":["Neurotoxin-based models of Parkinson's disease"],"prefix":"10.1016","volume":"211","author":[{"given":"J.","family":"Bov\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Perier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2011.10.057_bib1","series-title":"Movement disorders 2","first-page":"166","article-title":"Biochemistry of neurotransmitters in Parkinson's disease","author":"Agid","year":"1987"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pbb.2006.05.027","article-title":"Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats","volume":"84","author":"Aguiar","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2009.07.010","article-title":"Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats","volume":"240","author":"Alam","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbr.2003.12.021","article-title":"L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats","volume":"153","author":"Alam","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib6","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.69031326.x","article-title":"A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy Body disease","volume":"69","author":"Alam","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1471-4159.2008.05651.x","article-title":"Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid","volume":"107","author":"Alvarez-Fischer","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.expneurol.2007.10.012","article-title":"Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice","volume":"210","author":"Alvarez-Fischer","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1975.00490440064010","article-title":"Brain peroxidase and catalase in Parkinson disease","volume":"32","author":"Ambani","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/exnr.2000.7525","article-title":"Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3 nitropropionic acid, and MPTP","volume":"167","author":"Andreassen","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/BF00978370","article-title":"The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls","volume":"18","author":"Andrew","year":"1993","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1326-4-37","article-title":"Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance","volume":"4","author":"Arthur","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0306-4522(97)00665-9","article-title":"Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice","volume":"85","author":"Asanuma","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib16","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","article-title":"Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice","volume":"71","author":"Aubin","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0024-3205(86)90431-5","article-title":"Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Bankiewicz","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/mds.20124","article-title":"Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease","volume":"19","author":"Bara-Jimenez","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.expneurol.2009.07.019","article-title":"Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model","volume":"219","author":"Barraud","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib20","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1046\/j.1460-9568.1998.00345.x","article-title":"Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice","volume":"10","author":"Bensadoun","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1471-4159.1991.tb11444.x","article-title":"The iron chelator desferrioxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons","volume":"56","author":"Ben-Shachar","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib22","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.2402638","article-title":"Reversal of experimental parkinsonism by lesions of the subthalamic nucleus","volume":"249","author":"Bergman","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/cdd.2009.217","article-title":"Paraquat and Parkinson's disease","volume":"17","author":"Berry","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","article-title":"Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system","volume":"22","author":"Betarbet","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib25","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib26","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/exnr.1998.6995","article-title":"Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter","volume":"155","author":"Bezard","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(97)00531-3","article-title":"A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey","volume":"766","author":"Bezard","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/nbdi.2000.0375","article-title":"Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine monkeys","volume":"8","author":"Bezard","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib30","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1073\/pnas.022438099","article-title":"Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model","volume":"99","author":"Bjorklund","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.parkreldis.2004.02.011","article-title":"Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms","volume":"10","author":"Blanchet","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 2","key":"10.1016\/j.neuroscience.2011.10.057_bib32","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.parkreldis.2008.04.015","article-title":"The 6-hydroxydopamine model: news from the past","volume":"14","author":"Blandini","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3727\/096368909X479839","article-title":"Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat","volume":"19","author":"Blandini","year":"2010","journal-title":"Cell Transplant"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.expneurol.2009.05.017","article-title":"Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism","volume":"219","author":"Blume","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib35","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1021\/bi992296v","article-title":"Interaction between 6-hydroxydopamine and transferrin: \u201clet my iron go\u201d","volume":"39","author":"Borisenko","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib36","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.2042-7158.1972.tb08916.x","article-title":"Enhancement of audiogenic seizure by 6-hydroxydopamine","volume":"24","author":"Bourn","year":"1972","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/syn.10112","article-title":"Adenosine A2A antagonism reverses L-dopa-induced motor alterations in hemiparkinsonian rats","volume":"46","author":"Bov\u00e9","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"Bove","year":"2005","journal-title":"Neurorx"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/syn.20259","article-title":"Reversion of L-dopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats","volume":"59","author":"Bove","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00221-005-2302-1","article-title":"Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways","volume":"165","author":"Bove","year":"2005","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.20937","article-title":"Proteasome inhibition and Parkinson's disease modeling","volume":"60","author":"Bove","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib42","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/0006-2952(84)90344-7","article-title":"Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones","volume":"33","author":"Boyce","year":"1984","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 3","key":"10.1016\/j.neuroscience.2011.10.057_bib43","doi-asserted-by":"crossref","first-page":"III\/1","DOI":"10.1007\/s00415-002-1301-4","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-4827(74)90210-9","article-title":"Rotenone inhibition of spindle microtubule assembly in mammalian cells","volume":"85","author":"Brinkley","year":"1974","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib45","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01192-5","article-title":"Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss","volume":"823","author":"Brooks","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.freeradbiomed.2010.12.026","article-title":"Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease","volume":"50","author":"Broom","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib48","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of substantia nigra by N-methyl-4-phenyl,1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(89)91530-8","article-title":"Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence","volume":"476","author":"Cadet","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1471-4159.2007.05130.x","article-title":"Assessment of the direct and indirect effects of MPP+ and dopamine on the human proteasome: implications for Parkinson's disease aetiology","volume":"105","author":"Caneda-Ferr\u00f3n","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib52","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.127.3296.471","article-title":"On the presence of 3-hydroxytyramine in brain","volume":"127","author":"Carlsson","year":"1958","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib53","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","article-title":"3,4-dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists","volume":"180","author":"Carlsson","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib54","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur J Neurosci"},{"issue":"Suppl 4","key":"10.1016\/j.neuroscience.2011.10.057_bib55","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1353-8020(09)70828-4","article-title":"Rodent models of treatment-induced motor complications in Parkinson's disease","volume":"15","author":"Cenci","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1471-4159.1991.tb02134.x","article-title":"Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain","volume":"57","author":"Chan","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib57","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","article-title":"Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions","volume":"88","author":"Chang","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib59","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.0b013e3181d55f38","article-title":"Smoking duration, intensity, and risk of Parkinson disease","volume":"74","author":"Chen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib60","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A (2A) adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib61","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1523\/JNEUROSCI.5519-10.2011","article-title":"Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy","volume":"31","author":"Cheng","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib62","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0022-3565(25)22211-X","article-title":"Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"246","author":"Chiba","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib63","first-page":"342","article-title":"Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"13","author":"Chiba","year":"1985","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib64","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","article-title":"Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase","volume":"120","author":"Chiba","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib65","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(84)90221-8","article-title":"Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat","volume":"100","author":"Chiueh","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib66","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1083\/jcb.201009132","article-title":"Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model","volume":"192","author":"Choi","year":"2011","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuro.2010.04.006","article-title":"Mechanisms of rotenone-induced proteasome inhibition","volume":"31","author":"Chou","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib68","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"Cicchetti","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib69","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02244093","article-title":"Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease","volume":"102","author":"Close","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib70","first-page":"77","article-title":"Oxy-radical toxicity in catecholamine neurons","volume":"5","author":"Cohen","year":"1984","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib71","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/S0021-9258(19)42751-8","article-title":"The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents","volume":"249","author":"Cohen","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib72","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrn3039","article-title":"Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates","volume":"12","author":"Collier","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nbd.2006.11.013","article-title":"Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to Parkinsonism","volume":"26","author":"Collier","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/toxsci\/kfm309","article-title":"Letter regarding: \u201cParaquat: the red herring of Parkinson's disease research.\u201d","volume":"103","author":"Cory-Slechta","year":"2008","journal-title":"Toxicol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2011.10.057_bib75","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.3233\/JAD-2010-091525","article-title":"Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies","volume":"20","author":"Costa","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib76","first-page":"276","article-title":"Experimental treatment of parkinsonism with L-dopa","volume":"18","author":"Cotzias","year":"1968","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1021\/cn1001107","article-title":"JNK inhibition protects dopamine neurons and provides behavioral improvement in a Rat 6-hydroxydopamine model of Parkinson's disease","volume":"2","author":"Crocker","year":"2011","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib78","doi-asserted-by":"crossref","first-page":"13385","DOI":"10.1073\/pnas.231177098","article-title":"C-Jun mediates axotomy-induced dopamine neuron death in vivo","volume":"98","author":"Crocker","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib79","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.0953-816x.2001.01653.x","article-title":"NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease","volume":"14","author":"Crocker","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib80","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0021-9673(00)90882-3","article-title":"Mass fragmentography of dopamine and 6-hydroxydopamine","volume":"99","author":"Curtius","year":"1974","journal-title":"J Chromatogr"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib81","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1097\/00001756-199908200-00030","article-title":"Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration","volume":"10","author":"Cutillas","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/neur.1996.0020","article-title":"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model","volume":"5","author":"Cz\u0142onkowska","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib83","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP","volume":"99","author":"Dauer","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib84","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/bj2880439","article-title":"Uptake and accumulation of 1-methyl-4-phenylpyridinium by rat liver mitochondria measured using an ion-selective electrode","volume":"288","author":"Davey","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib85","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic parkinsonism secondary to intravenous injection of meperidine analogs","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib86","doi-asserted-by":"crossref","first-page":"12760","DOI":"10.1073\/pnas.96.22.12760","article-title":"A mechanism of paraquat toxicity involving nitric oxide synthase","volume":"96","author":"Day","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib87","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","article-title":"Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON collaborative study","volume":"62","author":"de Rijk","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib88","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1460-9568.2004.03586.x","article-title":"Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates","volume":"20","author":"Decamp","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib89","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.brainres.2009.01.028","article-title":"Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model","volume":"1262","author":"Decamp","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib90","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson's disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib91","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","article-title":"Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo","volume":"74","author":"Dehmer","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib92","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1460-9568.2003.03014.x","article-title":"Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease","volume":"18","author":"Depino","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib93","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib94","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib95","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10599240801986215","article-title":"Pesticide\/environmental exposures and Parkinson's disease in East Texas","volume":"13","author":"Dhillon","year":"2008","journal-title":"J Agromedicine"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib96","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainresbull.2005.08.009","article-title":"The corridor task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum","volume":"68","author":"Dowd","year":"2005","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib97","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2009.06.017","article-title":"Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology","volume":"36","author":"Drolet","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib98","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/1531-8257(199911)14:6<1011::AID-MDS1016>3.0.CO;2-F","article-title":"Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration","volume":"14","author":"Ebersbach","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib99","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jnr.21480","article-title":"Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3","volume":"86","author":"Ebert","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib100","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Verteilung von Noradrenalin und dopamine (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems","volume":"38","author":"Ehringer","year":"1960","journal-title":"Wiener Klinische Wochenschrift"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib101","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.nbd.2009.07.022","article-title":"Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF","volume":"36","author":"Emborg","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib102","first-page":"203","article-title":"Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta","volume":"73","author":"Eriksen","year":"2009","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib103","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/mds.22247","article-title":"Coffee, caffeine-related genes, and Parkinson's disease: a case-control study","volume":"23","author":"Facheris","year":"2008","journal-title":"Mov Disord"},{"issue":"26","key":"10.1016\/j.neuroscience.2011.10.057_bib104","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199612263352618","article-title":"The case of the frozen addicts: how the solution of an extraordinary medical mystery spawned a revolution in the understanding and treatment of Parkinson's disease","volume":"335","author":"Fahn","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson's disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib106","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0014-4886(69)90081-8","article-title":"Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra","volume":"23","author":"Faull","year":"1969","journal-title":"Exp Neurol"},{"issue":"Pt 5","key":"10.1016\/j.neuroscience.2011.10.057_bib107","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib108","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1074\/jbc.M708451200","article-title":"Paraquat neurotoxicity is mediated by a bak-dependent mechanism","volume":"283","author":"Fei","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib109","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0091-3057(99)00229-4","article-title":"The protective effects of PBN against MPTP toxicity are independent of hydroxyl radical trapping","volume":"65","author":"Ferger","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib110","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/syn.20456","article-title":"Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression","volume":"61","author":"Fernagut","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib111","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(97)00008-5","article-title":"Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra","volume":"753","author":"Ferrante","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib112","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.expneurol.2004.01.023","article-title":"Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone","volume":"187","author":"Fleming","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib113","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib114","first-page":"600","article-title":"Similarities and differences between MPTP-induced parkinsonism and Parkinson's disease: neuropathologic considerations","volume":"60","author":"Forno","year":"1993","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0079-6123(10)84007-5","article-title":"The MPTP-lesioned non-human primate models of Parkinson's disease","volume":"184","author":"Fox","year":"2010","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib116","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1017\/S0317167100009707","article-title":"Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's disease","volume":"37","author":"Fox","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib117","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jnr.21845","article-title":"1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys","volume":"87","author":"Garrido-Gil","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib118","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.82.24.8780","article-title":"The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey","volume":"82","author":"Gerfen","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib119","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1523\/JNEUROSCI.07-12-03935.1987","article-title":"The neostriatal mosaic: part III","volume":"7","author":"Gerfen","year":"1987","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib120","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib121","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1523\/JNEUROSCI.07-12-03915.1987","article-title":"The neostriatal mosaic: part II","volume":"7","author":"Gerfen","year":"1987","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib122","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib123","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.1992.tb24523.x","article-title":"Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced Parkinsonism: sparing of calbindin-D28k-containing cells","volume":"648","author":"German","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib124","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1021\/jm901618d","volume":"53","author":"Ghosh","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib125","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0022-3565(25)22504-6","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. part 2: central administration of 1-methyl-4-phenylpyridinium","volume":"270","author":"Giovanni","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib126","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib127","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2559.1980.tb02911.x","article-title":"Cerebral damage in paraquat poisoning","volume":"4","author":"Grant","year":"1980","journal-title":"Histopathology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib128","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/j.1460-9568.2010.07265.x","article-title":"Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease","volume":"31","author":"Grealish","year":"2010","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib129","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/nar\/gkn084","article-title":"Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease","volume":"36","author":"Gr\u00fcndemann","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib130","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/mt.2010.106","article-title":"Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC","volume":"18","author":"Hadaczek","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib131","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/mds.22481","article-title":"No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism","volume":"24","author":"Halliday","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib132","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1460-9568.2008.06097.x","article-title":"Differential activation of PKC delta in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesions","volume":"27","author":"Hanrott","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib133","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.102.039743","article-title":"Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates","volume":"303","author":"Hansard","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib134","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0306-4522(93)90295-Q","article-title":"Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons","volume":"53","author":"Hantraye","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/mt.2010.217","article-title":"Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease","volume":"19","author":"Harms","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib136","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1073\/pnas.040556597","article-title":"Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease","volume":"97","author":"Hartmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib137","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0006-291X(90)90498-C","article-title":"1-Mehtyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles","volume":"170","author":"Hasegawa","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib138","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0306-4522(95)00535-8","article-title":"Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus","volume":"72","author":"Hassani","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib139","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mds.21258","article-title":"Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease","volume":"22","author":"Hauser","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-8993(80)90871-9","article-title":"Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization","volume":"195","author":"Hefti","year":"1980","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib141","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0026-895X(25)12785-5","article-title":"Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine","volume":"8","author":"Heikkila","year":"1972","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib142","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib143","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0304-3940(85)90580-4","article-title":"Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity","volume":"62","author":"Heikkila","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib144","series-title":"Lake and stream rehabilitation: rotenone use and health risks","author":"Hisata","year":"2002"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"Hoglinger","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib146","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1471-4159.2005.03493.x","article-title":"The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy","volume":"95","author":"Hoglinger","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib147","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-3-211-45295-0_41","article-title":"The rotenone model of Parkinsonism\u2014the five years inspection","volume":"70","author":"Hoglinger","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib148","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nn1265","article-title":"Dopamine depletion impairs precursor cell proliferation in Parkinson disease","volume":"7","author":"Hoglinger","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib149","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/0006-291X(87)90931-4","article-title":"Inhibition of mitochondrial respiration by analogs of 4-phenylpyridine and 1-methyl-4-phenylpyridinium cation (MPP+), the neurotoxic metabolite of MPTP","volume":"148","author":"Hoppel","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1474-9726.2009.00543.x","article-title":"Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models","volume":"9","author":"Hu","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib151","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1523\/JNEUROSCI.4589-10.2011","article-title":"Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade","volume":"31","author":"Hu","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib152","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-4159.2009.06011.x","article-title":"Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys","volume":"109","author":"Huang","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib153","first-page":"243","article-title":"Brain damage due to paraquat poisoning: a fatal case with neuropathological examination of the brain","volume":"9","author":"Hughes","year":"1988","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib154","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","article-title":"JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease","volume":"101","author":"Hunot","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib155","unstructured":"Hutter-Saunders JA, Gendelman HE, Mosley RL (in press) Murine motor and behavior functional evaluations for acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication. J Neuroimmune Pharmacol, in press."},{"key":"10.1016\/j.neuroscience.2011.10.057_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","article-title":"Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice","volume":"162","author":"Iancu","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib157","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.0022-3042.2001.00694.x","article-title":"Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease","volume":"80","author":"Ikeda","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib158","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(99)00184-3","article-title":"Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the macaque monkey","volume":"96","author":"Imbert","year":"2000","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib159","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1248\/bpb.34.92","article-title":"Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL\/6 mice","volume":"34","author":"Inden","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib160","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.04440.x","article-title":"Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone","volume":"101","author":"Inden","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib161","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.neuint.2009.07.009","article-title":"Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice","volume":"55","author":"Inden","year":"2009","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib162","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1460-9568.2005.03915.x","article-title":"A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets","volume":"21","author":"Iravani","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib163","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/MNM.0b013e32832cc204","article-title":"Dopamine transporter imaging under high-dose transdervmal nicotine therapy in Parkinson's disease: an observational study","volume":"30","author":"Itti","year":"2009","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib164","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00702-009-0323-9","article-title":"The dopamine D (2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopa","volume":"117","author":"Jackson","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib166","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib167","first-page":"497","article-title":"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of Parkinson's disease, with emphasis on mice and nonhuman primates","volume":"54","author":"Jakowec","year":"2004","journal-title":"Comp Med"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib168","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1748-1716.1988.tb08372.x","article-title":"Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse","volume":"132","author":"Janson","year":"1988","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib169","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridinium by dopamine neurons explain selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1353-8020(02)00115-3","article-title":"The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease","volume":"9","author":"Jenner","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib171","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1212\/WNL.61.6_suppl_3.S4","article-title":"The MPTP-treated primate as a model of motor complications in PD: primate model of motor complications","volume":"61","author":"Jenner","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib172","first-page":"183","article-title":"MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects","volume":"45","author":"Jenner","year":"1987","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib173","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(84)90467-1","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset","volume":"50","author":"Jenner","year":"1984","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib174","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/neur.1995.0016","article-title":"6-hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death","volume":"4","author":"Jeon","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib175","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1471-4159.1999.0730322.x","article-title":"Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra","volume":"73","author":"Jeon","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib176","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.parkreldis.2004.06.004","article-title":"Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence","volume":"10","author":"Joghataie","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib177","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/mds.23249","article-title":"Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets","volume":"25","author":"Johnston","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib178","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.110.169532","article-title":"Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease","volume":"336","author":"Johnston","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib179","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbr.2010.07.023","article-title":"Topology of intrastriatal dopaminergic grafts determines functional and emotional outcome in neurotoxin-lesioned rats","volume":"216","author":"Jungnickel","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib180","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.expneurol.2010.02.007","article-title":"Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration","volume":"223","author":"Kachroo","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib181","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI42642","article-title":"Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease","volume":"120","author":"Karachi","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib182","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1096\/fj.06-7580com","article-title":"Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid","volume":"21","author":"Karunakaran","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib183","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1471-4159.2006.04177.x","article-title":"Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRs","volume":"100","author":"Khwaja","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib184","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1073\/pnas.062047599","article-title":"Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer","volume":"99","author":"Kirik","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib186","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0304-3940(85)90078-3","article-title":"Glutathione peroxidase activity in Parkinson's disease brain","volume":"58","author":"Kish","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib187","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1254\/jjp.78.23","article-title":"Protective effect of talipexole on MPTP-treated planarian, a unique parkinsonian worm model","volume":"78","author":"Kitamura","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib188","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/nbdi.1998.0191","article-title":"Manganese superoxide dismutase overexpression attenuates MPTP toxicity","volume":"5","author":"Klivenyi","year":"1998","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib189","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","article-title":"Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Kohutnicka","year":"1998","journal-title":"J Immunopharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1289\/ehp.877545","article-title":"MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease","volume":"75","author":"Kopin","year":"1987","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib191","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/mds.23631","article-title":"The selective mu-opioid receptor antagonist adl5510 reduces L-dopa-induced dyskinesia without affecting antiparkinsonian action in mptp-lesioned macaque model of Parkinson's disease","volume":"26","author":"Koprich","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib192","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.41.2_Part_1.202","article-title":"Early development of L-dopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease","volume":"41","author":"Kostic","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib193","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1601-183X.2010.00606.x","article-title":"Consistent behavioral phenotype differences between inbred mouse strains in the IntelliCage","volume":"9","author":"Krackow","year":"2010","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib194","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib195","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib196","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","article-title":"Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey","volume":"292","author":"Langston","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib197","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib198","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002826-198612000-00001","article-title":"MPTP: current concepts and controversies","volume":"9","author":"Langston","year":"1986","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib199","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1096\/fj.03-0677fje","article-title":"Rotenone induces non-specific central nervous system and systemic toxicity","volume":"18","author":"Lapointe","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib200","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","article-title":"Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat","volume":"72","author":"Lee","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib201","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0278-5846(03)00172-6","article-title":"Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease","volume":"28","author":"Lemay","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib202","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib203","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","article-title":"Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"339","author":"Limousin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib204","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","article-title":"Environmental risk factors and Parkinson's disease: a case-control study in Taiwan","volume":"48","author":"Liou","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib205","doi-asserted-by":"crossref","first-page":"9074","DOI":"10.1073\/pnas.89.19.9074","article-title":"Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium","volume":"89","author":"Liu","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib206","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/toxsci\/kfn028","article-title":"Response to \u201cparaquat: the red herring of Parkinson's disease research\u201d","volume":"103","author":"LoPachin","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib207","doi-asserted-by":"crossref","first-page":"38581","DOI":"10.1074\/jbc.M005385200","article-title":"The Parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation","volume":"275","author":"Lotharius","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib208","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-4328(89)80121-4","article-title":"Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage","volume":"33","author":"Luthman","year":"1989","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib209","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1046\/j.1471-4159.1998.71062439.x","article-title":"Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors","volume":"71","author":"Maggio","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib210","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein","volume":"277","author":"Manning-Bog","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib211","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1523\/JNEUROSCI.23-08-03095.2003","article-title":"Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration","volume":"23","author":"Manning-Bog","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib212","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1471-4159.2009.06189.x","article-title":"Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease","volume":"110","author":"Marinova-Mutafchieva","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib213","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/311464a0","article-title":"Intraneuronal generation of a pyridinium metabolite may cause drug-induced Parkinsonism","volume":"311","author":"Markey","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib214","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0304-4165(78)90315-X","article-title":"Rotenone inhibition of tubulin self-assembly","volume":"543","author":"Marshall","year":"1978","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib215","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1523\/JNEUROSCI.17-06-02030.1997","article-title":"Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra","volume":"17","author":"Marti","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib216","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(02)03694-6","article-title":"Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat","volume":"958","author":"Marti","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib217","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002130100687","article-title":"Limitations on the use of the C57BL\/6 mouse in the tail suspension test","volume":"155","author":"Mayorga","year":"2001","journal-title":"Psychopharmacol Berl"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib218","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1471-4159.2005.03088.x","article-title":"Role of oxidative stress in paraquat-induced dopaminergic cell degeneration","volume":"93","author":"McCormack","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib219","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1471-4159.2003.01621.x","article-title":"Effects of L-dopa and other amino acids against paraquat-induced nigrostriatal degeneration","volume":"85","author":"McCormack","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib221","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib222","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1385\/MN:28:3:209","article-title":"Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease","volume":"28","author":"Meissner","year":"2003","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib223","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneumeth.2008.09.017","article-title":"Objective quantification of arm rigidity in MPTP-treated primates","volume":"177","author":"Mera","year":"2009","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfm223","article-title":"Paraquat: the red herring of Parkinson's disease research","volume":"100","author":"Miller","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(85)90424-0","article-title":"Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus","volume":"61","author":"Mitchell","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib226","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainres.2003.10.035","article-title":"6-hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats","volume":"996","author":"Mladenovi\u0107","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib227","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0079-6123(08)62634-5","article-title":"Effects of nigral and striatal grafts on skilled forelimb use in the rat","volume":"82","author":"Montoya","year":"1990","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib228","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-0270(91)90048-5","article-title":"The \u201cstaircase test\u201d: a measure of independent forelimb reaching and grasping abilities in rats","volume":"36","author":"Montoya","year":"1991","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib229","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1073\/pnas.89.9.3859","article-title":"Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"89","author":"Moratalla","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib230","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neures.2004.11.008","article-title":"Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL\/6 mice","volume":"51","author":"Mori","year":"2005","journal-title":"Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib231","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/brain\/awm208","article-title":"A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery","volume":"130","author":"Mounayar","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib232","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/brain\/awn235","article-title":"Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia","volume":"131","author":"Mu\u00f1oz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib233","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/exnr.1994.1058","article-title":"Differences in nigral neuron number and sensitivity to 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine in C57\/bl and CD-1mice","volume":"126","author":"Muthane","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib234","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib235","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3171\/jns.2003.98.1.0136","article-title":"Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease","volume":"98","author":"Oiwa","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib236","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib237","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0197-4580(95)02012-8","article-title":"Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys","volume":"16","author":"Ovadia","year":"1995","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib238","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-8-9","article-title":"CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease","volume":"8","author":"Pabon","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib239","doi-asserted-by":"crossref","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","article-title":"Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice","volume":"5","author":"Pan-Montojo","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(94)90796-X","article-title":"Motor fluctuations in L-dopa treated parkinsonian rats: relation to lesion extent and treatment duration","volume":"662","author":"Papa","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib241","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0006-8993(03)03195-0","article-title":"Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine parkinsonian toxin","volume":"984","author":"Parain","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib242","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib243","doi-asserted-by":"crossref","first-page":"32626","DOI":"10.1074\/jbc.M404596200","article-title":"The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway","volume":"279","author":"Peng","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib244","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1471-4159.2010.07036.x","article-title":"Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration","volume":"115","author":"Peng","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib245","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1523\/JNEUROSCI.1569-07.2007","article-title":"Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration","volume":"27","author":"Peng","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib246","doi-asserted-by":"crossref","first-page":"29194","DOI":"10.1074\/jbc.M500984200","article-title":"Superoxide dismutase\/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease","volume":"280","author":"Peng","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib247","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2008.10.045","article-title":"Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation","volume":"46","author":"Peng","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib248","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0006-8993(91)91444-6","article-title":"Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset","volume":"567","author":"P\u00e9rez-Ota\u00f1o","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib249","unstructured":"Perier C, Bove J, Vila M (in press) Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond. Antioxid Redox Signal, in press."},{"key":"10.1016\/j.neuroscience.2011.10.057_bib250","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0609874104","article-title":"Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease","volume":"104","author":"Perier","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib251","doi-asserted-by":"crossref","first-page":"19126","DOI":"10.1073\/pnas.0508215102","article-title":"Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage","volume":"102","author":"Perier","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib252","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.0953-816X.2003.03089.x","article-title":"Disruption of self-organized actions in monkeys with progressive MPTP-induced Parkinsonism: part II","volume":"19","author":"Pessiglione","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib253","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/jm00148a010","article-title":"Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"28","author":"Peterson","year":"1985","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib254","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib255","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuropharm.2004.11.009","article-title":"KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse","volume":"48","author":"Pierri","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib256","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1517\/13543780903241615","article-title":"Novel investigational adenosine A2A receptor antagonists for Parkinson's disease","volume":"18","author":"Pinna","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib257","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/syn.20410","article-title":"Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease","volume":"61","author":"Pinna","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib258","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0022-3565(25)26555-7","article-title":"Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice","volume":"140","author":"Porter","year":"1963","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib259","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.expneurol.2008.11.003","article-title":"Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain","volume":"215","author":"Prasad","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib260","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.expneurol.2006.07.001","article-title":"The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease","volume":"202","author":"Prediger","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib261","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1749-6632.2009.03885.x","article-title":"Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson's disease","volume":"1170","author":"Prediger","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib262","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/ars.2005.7.685","article-title":"Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease","volume":"7","author":"Przedborski","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib263","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1471-4159.1992.tb10051.x","article-title":"Superoxide dismutase, catalase, and glutathione peroxidase activities in copper\/zinc-superoxide dismutase transgenic mice","volume":"58","author":"Przedborski","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib264","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib265","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","article-title":"Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine","volume":"67","author":"Przedborski","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib266","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1566-2772(01)00019-6","article-title":"MPTP: a review of its mechanisms of neurotoxicity","volume":"1","author":"Przedborski","year":"2001","journal-title":"Clin Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib267","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","article-title":"The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease","volume":"991","author":"Przedborski","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib268","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2006.10.008","article-title":"Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration","volume":"25","author":"Purisai","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib269","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2006.04078.x","article-title":"Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates","volume":"98","author":"Quik","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib270","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archneur.65.5.577","article-title":"Tesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS study","volume":"65","author":"Rascol","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib271","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-3565(25)23492-9","article-title":"Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain","volume":"249","author":"Riachi","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib272","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jnr.21159","article-title":"Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice","volume":"85","author":"Richter","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib273","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1073\/pnas.0606401103","article-title":"Oncoprotein Akt\/PKB induces trophic effects in murine models of Parkinson's disease","volume":"103","author":"Ries","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib274","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1471-4159.2008.05713.x","article-title":"JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration","volume":"107","author":"Ries","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib275","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/archneur.64.7.990","article-title":"Pooled analysis of tobacco use and risk of Parkinson disease","volume":"64","author":"Ritz","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib276","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/j.1460-9568.2006.05060.x","article-title":"Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice","volume":"24","author":"Rojo","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib277","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1471-4159.2009.06220.x","article-title":"Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication","volume":"110","author":"Rolland","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib278","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1073\/pnas.1017820108","article-title":"Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism","volume":"108","author":"Ros-Bernal","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib279","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2006.07.017","article-title":"The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets","volume":"546","author":"Rose","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib280","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2006.10.038","article-title":"The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of L-dopa in unilaterally 6-OHDA-lesioned rats","volume":"1133","author":"Rose","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib281","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1016\/0006-2952(88)90674-0","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro","volume":"37","author":"Rossetti","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib282","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/nm1495","article-title":"Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes","volume":"12","author":"Roy","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib283","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-0270(98)00078-8","article-title":"The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism","volume":"83","author":"Rozas","year":"1998","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib284","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3940(91)90171-O","article-title":"Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?","volume":"123","author":"Russ","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib285","series-title":"The principles of humane experimental technique","author":"Russell","year":"1959"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib286","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/sj.bjp.0703989","article-title":"Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice","volume":"132","author":"Ryan","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib287","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","article-title":"A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys","volume":"39","author":"Rylander","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib288","first-page":"197","article-title":"A marker of oxyradical-mediated DNA damage (8-Hydroxy-2deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain","volume":"3","author":"Sanchez-Ramos","year":"1994","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib289","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0026-895X(25)12658-8","article-title":"Model experiments on the molecular mechanism of action of 6-hydroxydopamine","volume":"7","author":"Saner","year":"1971","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1471-4159.2004.02471.x","article-title":"In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats","volume":"90","author":"Sarre","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib291","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib292","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1471-4159.2003.01676.x","article-title":"Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity","volume":"85","author":"Saura","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib293","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib294","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0005-2728(01)00183-9","article-title":"Functional coupling of PSST and ND1 subunits in NADH: ubiquinone oxidoreductase established by photoaffinity labeling","volume":"1506","author":"Schuler","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib296","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1471-4159.2000.0750511.x","article-title":"Neuroblastoma cells expressing the noradrenaline transporter are destroyed more selectively by 6-fluorodopamine than by 6-hydroxydopamine","volume":"75","author":"Seitz","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib297","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(90)91055-L","article-title":"Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP","volume":"527","author":"Seniuk","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib298","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib299","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(01)02577-X","article-title":"Carrier-mediated processes in blood-brain barrier penetration and neural uptake of paraquat","volume":"906","author":"Shimizu","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib300","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WNF.0b013e31815a3f03","article-title":"Caffeine and progression of Parkinson disease","volume":"31","author":"Simon","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib301","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/glia.20233","article-title":"Glia cell number modulates sensitivity to MPTP in mice","volume":"52","author":"Smeyne","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib302","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/096032718800700103","article-title":"Paraquat poisoning by skin absorption: a review","volume":"7","author":"Smith","year":"1988","journal-title":"Hum Toxicol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib303","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0306-4522(93)90176-G","article-title":"Developing a stable bilateral model of parkinsonism in rhesus monkeys","volume":"52","author":"Smith","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib304","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/jnnp.68.3.313","article-title":"Pattern of dopaminergic loss in the striatum of humans with MPTP induced Parkinsonism","volume":"68","author":"Snow","year":"2000","journal-title":"J Neurol Neurosurg, Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib305","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","article-title":"Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease","volume":"142","author":"Sofic","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib306","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1046\/j.1471-4159.2000.0741605.x","article-title":"Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease","volume":"74","author":"Soto-Otero","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib307","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nbd.2010.03.009","article-title":"Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss","volume":"39","author":"Spieles-Engemann","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib308","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","article-title":"Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease","volume":"16","author":"Sriram","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib309","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0022-3565(24)39240-7","article-title":"Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata","volume":"293","author":"Staal","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib310","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ana.410400417","article-title":"Origin and functional consequences of the complex I defect in Parkinson's disease","volume":"40","author":"Swerdlow","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib311","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jnr.21869","article-title":"Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models","volume":"87","author":"Takeuchi","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib312","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1046\/j.1471-4159.2000.0752611.x","article-title":"In vivo labeling of mitochondrial complex I (NADH: ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone","volume":"75","author":"Talpade","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib313","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib314","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jnr.22201","article-title":"Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model","volume":"88","author":"Tapias","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib315","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib316","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.expneurol.2010.09.007","article-title":"The partial dopamine agonist pardoprunox (SLV308) administered in combination with L-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets","volume":"226","author":"Tayarani-Binazir","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib317","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0306-4522(97)00214-5","article-title":"Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)","volume":"81","author":"Taylor","year":"1997","journal-title":"Neuroscience"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2011.10.057_bib318","first-page":"308","article-title":"MPTP-induced tremor in human and non-human primates","volume":"36","author":"Tetrud","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib319","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/01.wnl.0000256374.50227.4b","article-title":"Temporal relationship between cigarette smoking and risk of Parkinson disease","volume":"68","author":"Thacker","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib320","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-8993(00)02960-7","article-title":"Increased striatal dopamine turnover following acute administration of rotenone to mice","volume":"885","author":"Thiffault","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib321","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0006-8993(00)02496-3","article-title":"Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?","volume":"873","author":"Thiruchelvam","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib322","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","article-title":"The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease","volume":"20","author":"Thiruchelvam","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib323","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib324","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.1523\/JNEUROSCI.16-23-07776.1996","article-title":"Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons","volume":"16","author":"Todd","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib325","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/WNL.0b013e318198db11","article-title":"Diagnosis and the premotor phase of Parkinson disease","volume":"72","author":"Tolosa","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib326","series-title":"Contribution a l\u2019etude de l'anatomie pathologique du locus Niger de Soemmering avec quelques deductions relatives a la pathogenie des troubles du tonus musculaire et de la maladie de Parkinson","author":"Tretiakoff","year":"1919"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib327","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2007.03.021","article-title":"Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats","volume":"566","author":"Tronci","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib328","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-hydroxydopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib329","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-201X.1971.tb11001.x","article-title":"Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib330","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptique supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal system in the rat brain","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib331","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib332","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2202-11-92","article-title":"Automated quantitative gait analysis in animal models of movement disorders","volume":"11","author":"Vandeputte","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib333","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbr.2009.01.022","article-title":"Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease","volume":"200","author":"Verhave","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib334","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1212\/WNL.57.6.1032","article-title":"Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study","volume":"57","author":"Vieregge","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib335","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/auto.7.1.13933","article-title":"Lysosomal membrane permeabilization in Parkinson disease","volume":"7","author":"Vila","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib336","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.051633998","article-title":"Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"98","author":"Vila","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib337","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn1100","article-title":"Targeting programmed cell death in neurodegenerative diseases","volume":"4","author":"Vila","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib338","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-4159.2008.05604.x","article-title":"Mitochondrial alterations in Parkinson's disease: new clues","volume":"107","author":"Vila","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib339","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib340","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1468-1331.2007.01949.x","article-title":"Chronic high dose transdermal nicotine in Parkinson's disease: an open trial","volume":"14","author":"Villafane","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib341","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.expneurol.2008.09.025","article-title":"Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys","volume":"215","author":"Villalba","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib342","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.410360513","article-title":"Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions","volume":"36","author":"Vingerhoets","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib343","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.neuropharm.2006.04.015","article-title":"Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle","volume":"51","author":"Visanji","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib344","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/neu.10173","article-title":"Different data from different labs: lessons from studies of gene-environment interaction","volume":"54","author":"Wahlsten","year":"2003","journal-title":"J Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib345","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10654-011-9574-5","article-title":"Parkinson's disease risk from ambient exposure to pesticides","volume":"26","author":"Wang","year":"2011","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib346","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(87)90033-3","article-title":"Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice","volume":"402","author":"Willis","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib347","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib348","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1089\/ars.2005.7.654","article-title":"The role of microglia in paraquat-induced dopaminergic neurotoxicity","volume":"7","author":"Wu","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib349","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neuroscience.2010.02.020","article-title":"Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease","volume":"167","author":"Xu","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib350","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/brain\/awq144","article-title":"Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease","volume":"133","author":"Zaidel","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2011.10.057_bib351","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cne.20305","article-title":"Variable effects of chronic subcutaneous administration of rotenone on striatal histology","volume":"478","author":"Zhu","year":"2004","journal-title":"J Comp Neurol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452211012668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452211012668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:04:06Z","timestamp":1741910646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452211012668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":351,"alternative-id":["S0306452211012668"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2011.10.057","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}